{
    "2020-08-19": [
        [
            {
                "time": "2021-12-01",
                "original_text": "Johnson & Johnson stock outperforms market on strong trading day",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "outperforms",
                        "strong trading day"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "BioMarin Stock Slumps After FDA’s Surprise Rejection of a Hemophilia Gene Therapy",
                "features": {
                    "keywords": [
                        "BioMarin",
                        "Slumps",
                        "FDA",
                        "Rejection",
                        "Hemophilia Gene Therapy"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "Potential Gilead Blockbusters Were Rejected By the FDA. Why That’s the ‘Near-Worst-Case Scenario’ for the Stock.",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Blockbusters",
                        "Rejected",
                        "FDA",
                        "Worst-Case Scenario"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "German institute says coronavirus vaccinations could start in early 2021",
                "features": {
                    "keywords": [
                        "coronavirus",
                        "vaccinations",
                        "early 2021"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}